X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (329) 329
humans (303) 303
newly-diagnosed myeloma (269) 269
multiple myeloma (239) 239
oncology (203) 203
hematology (191) 191
stem-cell transplantation (164) 164
multiple myeloma - drug therapy (154) 154
bortezomib (119) 119
thalidomide (119) 119
male (116) 116
female (114) 114
aged (112) 112
lenalidomide (112) 112
middle aged (105) 105
multiple myeloma - therapy (104) 104
antineoplastic combined chemotherapy protocols - therapeutic use (95) 95
thalidomide - analogs & derivatives (94) 94
treatment outcome (90) 90
adult (87) 87
combination therapy (77) 77
transplantation (77) 77
chemotherapy (76) 76
care and treatment (75) 75
antineoplastic agents - therapeutic use (74) 74
cancer (70) 70
lenalidomide plus dexamethasone (69) 69
thalidomide - therapeutic use (67) 67
therapy (67) 67
dexamethasone (65) 65
multiple myeloma - mortality (63) 63
autologous transplantation (62) 62
plus dexamethasone (57) 57
thalidomide - administration & dosage (56) 56
survival (55) 55
stem cells (53) 53
transplantation, autologous (53) 53
newly diagnosed (50) 50
hematology, oncology and palliative medicine (49) 49
elderly-patients (48) 48
thalidomide plus dexamethasone (48) 48
high-dose therapy (47) 47
dexamethasone - administration & dosage (46) 46
aged, 80 and over (45) 45
stem cell transplantation (45) 45
disease-free survival (43) 43
drug therapy (42) 42
health aspects (42) 42
clinical trials as topic (41) 41
myeloma (41) 41
prognosis (41) 41
antineoplastic combined chemotherapy protocols - adverse effects (40) 40
thalidomide - adverse effects (40) 40
research (39) 39
trial (39) 39
hematopoietic stem cell transplantation (37) 37
multiple myeloma - diagnosis (37) 37
patients (37) 37
pharmacology & pharmacy (37) 37
term-follow-up (36) 36
retrospective studies (34) 34
risk factors (34) 34
immunology (33) 33
prednisone (33) 33
survival analysis (33) 33
medicine & public health (32) 32
melphalan (32) 32
newly-diagnosed patients (32) 32
maintenance therapy (31) 31
pegylated liposomal doxorubicin (31) 31
randomized controlled-trial (31) 31
randomized-trial (31) 31
bone-marrow-transplantation (30) 30
combined modality therapy (30) 30
hematopoietic stem cell transplantation - methods (30) 30
multiple myeloma - pathology (30) 30
analysis (29) 29
antineoplastic agents - adverse effects (29) 29
article (29) 29
clinical trials (28) 28
hematopoietic stem cells (28) 28
survival rate (28) 28
boronic acids - therapeutic use (27) 27
pyrazines - therapeutic use (27) 27
medicine, general & internal (26) 26
cyclophosphamide (25) 25
phase-iii (25) 25
transplantation, homologous (25) 25
animals (24) 24
antineoplastic agents - administration & dosage (24) 24
multiple myeloma - complications (24) 24
newly-diagnosed glioblastoma (24) 24
patient outcomes (24) 24
boronic acids - administration & dosage (23) 23
multiple myeloma - surgery (23) 23
recurrence (23) 23
abridged index medicus (22) 22
pyrazines - administration & dosage (22) 22
low-dose dexamethasone (21) 21
phase-ii (21) 21
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica, ISSN 0390-6078, 01/2015, Volume 100, Issue 10, pp. 1254 - 1266
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 10/2009, Volume 23, Issue 10, pp. 1904 - 1912
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 11/2015, Volume 13, Issue 11, pp. 1398 - 1435
Multiple myeloma (MM) is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. Recent statistics... 
SINGLE-AGENT CARFILZOMIB | DONOR LYMPHOCYTE INFUSIONS | THALIDOMIDE PLUS DEXAMETHASONE | INDUCTION THERAPY | ONCOLOGY | HIGH-DOSE THERAPY | LONG-TERM SURVIVAL | NEWLY-DIAGNOSED MYELOMA | PHASE-III | NATIONAL-CANCER-INSTITUTE | STEM-CELL TRANSPLANTATION
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 21, pp. 2133 - 2142
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 10/2018, Volume 59, Issue 10, pp. 2305 - 2317
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 13, pp. 1195 - 1203
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 11/2006, Volume 1, Issue 6, pp. 1322 - 1330
Journal Article